{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Enzymatic Creatinine 2",
        "ADVIA Chemistry Enzymatic Creatinine_2",
        "ADVIA\u00ae Chemistry Enzymatic Creatinine2 (ECRE_2)"
    ],
    "Submitter Information": "Siemens Medical Solutions Diagnostics",
    "510(k) Number": "K070727",
    "Predicate Device Reference 510(k) Number(s)": [
        "k973993",
        "k991576"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY"
    ],
    "Summary Letter Date": "August 3, 2007",
    "Summary Letter Received Date": "July 23, 2007",
    "Submission Date": "July 20, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "K2EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry 1200",
        "ADVIA Chemistry 1650",
        "ADVIA Chemistry 1800",
        "ADVIA Chemistry 2400"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Colorimetric endpoint detection"
    ],
    "Methodologies": [
        "Enzymatic method using creatininase, creatinase, sarcosine oxidase, peroxidase"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry Enzymatic Creatinine 2 assay for quantitative measurement of creatinine in serum, plasma, or urine using ADVIA Chemistry analyzers",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma, and urine on the ADVIA Chemistry Systems for diagnosis and treatment of renal diseases and monitoring renal dialysis",
    "fda_folder": "Clinical Chemistry"
}